Main inclusion criteria
Clinical application and evaluation of pharmaceutical small molecules, therapeutic vaccines, antibodies and hormones in humans including:
- small scale settings and pilot studies
- phase I, II, III and IV trials
- assessing sensitivity, efficacy, specificity, relapse, survival, therapeutic value, pharmacokinetics, reproducibility and safety
- studies monitoring response, outcome, drug resistance and side effects
Advice on research activities
Includes studies of nutritional supplements used as treatments for disease.
Excludes studies focused on the potentially chemopreventative / health protective effects of specific nutrients, probiotics and nutritional supplements, which should be coded 3.3 Nutritional Prevention.
Full name of code
|Short name||Unique ID|
|6.1 Pharmaceuticals||6.1 Pharmaceutical||
Related external links
Common Scientific Outline (CSO) – 5.4 Systemic Therapies – Clinical Applications